Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2292 | 2292 | 42.5 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
419 | 2 | STATINS//EZETIMIBE//SIMVASTATIN | 16502 |
2292 | 1 | STATINS//ATORVASTATIN//HMG COA REDUCTASE INHIBITORS | 2292 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | STATINS | authKW | 1063465 | 33% | 10% | 765 |
2 | ATORVASTATIN | authKW | 300439 | 9% | 11% | 202 |
3 | HMG COA REDUCTASE INHIBITORS | authKW | 220639 | 6% | 13% | 131 |
4 | FLUVASTATIN | authKW | 194172 | 3% | 19% | 76 |
5 | PLEIOTROPIC EFFECTS | authKW | 183820 | 3% | 21% | 65 |
6 | SIMVASTATIN | authKW | 128191 | 6% | 7% | 142 |
7 | PRAVASTATIN | authKW | 83432 | 3% | 9% | 69 |
8 | ROSUVASTATIN | authKW | 65599 | 3% | 9% | 58 |
9 | 3 HYDROXY 3 METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS | authKW | 64002 | 1% | 19% | 25 |
10 | CERIVASTATIN | authKW | 42904 | 1% | 17% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 34724 | 48% | 0% | 1105 |
2 | Peripheral Vascular Diseases | 13724 | 23% | 0% | 528 |
3 | Pharmacology & Pharmacy | 2588 | 21% | 0% | 491 |
4 | Hematology | 634 | 6% | 0% | 134 |
5 | Medicine, Research & Experimental | 342 | 6% | 0% | 131 |
6 | Medicine, General & Internal | 318 | 7% | 0% | 163 |
7 | Respiratory System | 167 | 3% | 0% | 65 |
8 | Physiology | 116 | 3% | 0% | 80 |
9 | Anesthesiology | 35 | 1% | 0% | 25 |
10 | Endocrinology & Metabolism | 18 | 2% | 0% | 56 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VASC MED ATHEROSCLEROSIS UNIT | 31817 | 1% | 17% | 14 |
2 | CARDIOL | 28398 | 25% | 0% | 581 |
3 | EMI 99 12 | 26642 | 0% | 100% | 2 |
4 | YONSEI SEVERANCE HOSP | 26642 | 0% | 100% | 2 |
5 | GIL HEART | 20781 | 0% | 20% | 8 |
6 | LIPID THROMBOSIS | 17760 | 0% | 67% | 2 |
7 | PATOL VASC NEFROL EXPT | 17760 | 0% | 67% | 2 |
8 | ACCID EMERGENCY DIRECTORATE | 17123 | 0% | 43% | 3 |
9 | A205 CLIN | 13321 | 0% | 100% | 1 |
10 | ACUTE CORONARY CARE | 13321 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS | 10282 | 4% | 1% | 91 |
2 | AMERICAN JOURNAL OF CARDIOLOGY | 9954 | 6% | 1% | 142 |
3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 5669 | 3% | 1% | 69 |
4 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 5512 | 2% | 1% | 56 |
5 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 4428 | 1% | 2% | 14 |
6 | INTERNATIONAL JOURNAL OF CARDIOLOGY | 4381 | 3% | 1% | 63 |
7 | CIRCULATION | 3571 | 4% | 0% | 82 |
8 | CIRCULATION JOURNAL | 3491 | 2% | 1% | 35 |
9 | CARDIOVASCULAR DRUGS AND THERAPY | 2996 | 1% | 1% | 21 |
10 | CURRENT ATHEROSCLEROSIS REPORTS | 2878 | 1% | 2% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STATINS | 1063465 | 33% | 10% | 765 | Search STATINS | Search STATINS |
2 | ATORVASTATIN | 300439 | 9% | 11% | 202 | Search ATORVASTATIN | Search ATORVASTATIN |
3 | HMG COA REDUCTASE INHIBITORS | 220639 | 6% | 13% | 131 | Search HMG+COA+REDUCTASE+INHIBITORS | Search HMG+COA+REDUCTASE+INHIBITORS |
4 | FLUVASTATIN | 194172 | 3% | 19% | 76 | Search FLUVASTATIN | Search FLUVASTATIN |
5 | PLEIOTROPIC EFFECTS | 183820 | 3% | 21% | 65 | Search PLEIOTROPIC+EFFECTS | Search PLEIOTROPIC+EFFECTS |
6 | SIMVASTATIN | 128191 | 6% | 7% | 142 | Search SIMVASTATIN | Search SIMVASTATIN |
7 | PRAVASTATIN | 83432 | 3% | 9% | 69 | Search PRAVASTATIN | Search PRAVASTATIN |
8 | ROSUVASTATIN | 65599 | 3% | 9% | 58 | Search ROSUVASTATIN | Search ROSUVASTATIN |
9 | 3 HYDROXY 3 METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS | 64002 | 1% | 19% | 25 | Search 3+HYDROXY+3+METHYLGLUTARYL+COENZYME+A+REDUCTASE+INHIBITORS | Search 3+HYDROXY+3+METHYLGLUTARYL+COENZYME+A+REDUCTASE+INHIBITORS |
10 | CERIVASTATIN | 42904 | 1% | 17% | 19 | Search CERIVASTATIN | Search CERIVASTATIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OSTADAL, P , (2012) STATINS AS FIRST-LINE THERAPY FOR ACUTE CORONARY SYNDROME?.EXPERIMENTAL & CLINICAL CARDIOLOGY. VOL. 17. ISSUE 4. P. 227 -236 | 87 | 60% | 2 |
2 | KUHN, EW , LIAKOPOULOS, OJ , STANGE, S , DEPPE, AC , SLOTTOSCH, I , CHOI, YH , WAHLERS, T , (2014) PREOPERATIVE STATIN THERAPY IN CARDIAC SURGERY: A META-ANALYSIS OF 90 000 PATIENTS.EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. VOL. 45. ISSUE 1. P. 17-26 | 50 | 76% | 27 |
3 | DRAPALA, A , SIKORA, M , UFNAL, M , (2014) STATINS, THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND HYPERTENSION - A TALE OF ANOTHER BENEFICIAL EFFECT OF STATINS.JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. VOL. 15. ISSUE 3. P. 250 -258 | 71 | 55% | 9 |
4 | DE GENNARO, L , BRUNETTI, ND , CORREALE, M , BUQUICCHIO, F , CALDAROLA, P , DI BIASE, M , (2014) STATIN THERAPY IN HEART FAILURE: FOR GOOD, FOR BAD, OR INDIFFERENT?.CURRENT ATHEROSCLEROSIS REPORTS. VOL. 16. ISSUE 1. P. - | 49 | 82% | 3 |
5 | UNDAS, A , CELINSKA-LOWENHOFF, M , KACZOR, M , MUSIAL, J , (2004) NEW NONLIPID EFFECTS OF STATINS AND THEIR CLINICAL RELEVANCE IN CARDIOVASCULAR DISEASE.THROMBOSIS AND HAEMOSTASIS. VOL. 91. ISSUE 6. P. 1065 -1077 | 77 | 62% | 42 |
6 | MASON, JC , (2003) STATINS AND THEIR ROLE IN VASCULAR PROTECTION.CLINICAL SCIENCE. VOL. 105. ISSUE 3. P. 251-266 | 92 | 50% | 80 |
7 | BONETTI, PO , LERMAN, LO , NAPOLI, C , LERMAN, A , (2003) STATIN EFFECTS BEYOND LIPID LOWERING-ARE THEY CLINICALLY RELEVANT?.EUROPEAN HEART JOURNAL. VOL. 24. ISSUE 3. P. 225-248 | 82 | 43% | 276 |
8 | LUDMAN, A , VENUGOPAL, V , YELLON, DM , HAUSENLOY, DJ , (2009) STATINS AND CARDIOPROTECTION - MORE THAN JUST LIPID LOWERING?.PHARMACOLOGY & THERAPEUTICS. VOL. 122. ISSUE 1. P. 30-43 | 60 | 56% | 83 |
9 | BARAKAT, AF , SAAD, M , ABUZAID, A , MENTIAS, A , MAHMOUD, A , ELGENDY, IY , (2016) PERIOPERATIVE STATIN THERAPY FOR PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING.ANNALS OF THORACIC SURGERY. VOL. 101. ISSUE 2. P. 818 -825 | 46 | 68% | 1 |
10 | BELTOWSKI, J , (2005) STATINS AND MODULATION OF OXIDATIVE STRESS.TOXICOLOGY MECHANISMS AND METHODS. VOL. 15. ISSUE 2. P. 61-92 | 123 | 35% | 8 |
Classes with closest relation at Level 1 |